The risk of incident coronary heart disease among veterans with and without HIV and hepatitis C - Wikidata - wikimedia - TriplyDB

The risk of incident coronary heart disease among veterans with and without HIV and hepatitis C

The risk of incident coronary heart disease among veterans with and without HIV and hepatitis C

http://www.wikidata.org/entity/Q35174850

about

HIV infection and the risk of acute myocardial infarction.Increased cardiovascular disease risk in the HIV-positive population on ART: potential role of HIV-Nef and Tat Effects of Therapy with Maraviroc on the Carotid Intima Media Thickness in HIV-1/HCV Co-infected Patients.Hepatitis C virus and metabolic disorder interactions towards liver damage and atherosclerosis.Cardiovascular risk prediction in HIV-infected patients: comparing the Framingham, atherosclerotic cardiovascular disease risk score (ASCVD), Systematic Coronary Risk Evaluation for the Netherlands (SCORE-NL) and Data Collection on Adverse Events of Human immunodeficiency virus, hepatitis C, and inflammatory biomarkers in individuals with alcohol problems: a cross-sectional study.Pulmonary symptoms and diagnoses are associated with HIV in the MACS and WIHS cohorts.Initiation of antiretroviral therapy at high CD4 cell counts: does it reduce the risk of cardiovascular disease?Changes in inflammatory biomarkers in HCV-infected patients undergoing direct acting antiviral-containing regimens with or without interferon Epidemiology of coronary heart disease in patients with human immunodeficiency virus HIV-1 transgenic rats display alterations in immunophenotype and cellular responses associated with aging.T-cell phenotypes, apoptosis and inflammation in HIV+ patients on virologically effective cART with early atherosclerosis Hepatic decompensation in antiretroviral-treated patients co-infected with HIV and hepatitis C virus compared with hepatitis C virus-monoinfected patients: a cohort study.HIV/hepatitis C virus coinfection ameliorates the atherogenic lipoprotein abnormalities of HIV infection Medical ICU admission diagnoses and outcomes in human immunodeficiency virus-infected and virus-uninfected veterans in the combination antiretroviral era The effect of hepatitis C virologic clearance on cardiovascular disease biomarkers in human immunodeficiency virus/hepatitis C virus coinfection Transfer of intracellular HIV Nef to endothelium causes endothelial dysfunction.Impact of hepatitis C seropositivity on the risk of coronary heart disease events.Essential components of effective HIV care: a policy paper of the HIV Medicine Association of the Infectious Diseases Society of America and the Ryan White Medical Providers Coalition.HIV status and the risk of ischemic stroke among men.Long-term Prescription of Opioids and/or Benzodiazepines and Mortality Among HIV-Infected and Uninfected Patients Low-Density Lipoprotein Cholesterol Levels and Statin Treatment by HIV Status Among Multicenter AIDS Cohort Study Men.Association of HIV, hepatitis C virus and liver fibrosis severity with interleukin-6 and C-reactive protein levels Hormonal Contraception and Risk of Psychiatric and Other Noncommunicable Diseases in HIV-Infected Women.Smoking, death, and Alzheimer disease: a case of competing risks HIV infection and coronary heart disease: an intersection of epidemics Pentoxifylline reduces tumor necrosis factor-α and HIV-induced vascular endothelial activation.Short communication: risk of elevated total cholesterol/high-density lipoprotein cholesterol ratio after antiretroviral therapy in HIV/hepatitis C virus patients.Receipt of opioid analgesics by HIV-infected and uninfected patients HIV and Hepatitis C-Coinfected Patients Have Lower Low-Density Lipoprotein Cholesterol Despite Higher Proprotein Convertase Subtilisin Kexin 9 (PCSK9): An Apparent "PCSK9-Lipid Paradox".Disparities in Absolute Denial of Modern Hepatitis C Therapy by Type of Insurance.Trends in Any and High-Dose Opioid Analgesic Receipt Among Aging Patients With and Without HIV Serious Non-AIDS events: Immunopathogenesis and interventional strategies.Chronic hepatitis C virus infection is associated with all-cause and liver-related mortality in a cohort of HIV-infected patients with alcohol problems Cardiovascular disease and HIV infection.Lessons learned from the design and implementation of myocardial infarction adjudication tailored for HIV clinical cohorts.The impact of hepatitis C burden: an evidence-based approach.HIV, highly active antiretroviral therapy and the heart: a cellular to epidemiological review.Chronic hepatitis C virus infection, a new cardiovascular risk factor?Serious Non-AIDS Events: Therapeutic Targets of Immune Activation and Chronic Inflammation in HIV Infection

P2860

Q27347231-82770B16-03CD-4446-ABE7-F108DC4213A0 Q28080948-090FA9B7-4899-4CCA-B43A-3A586D3F16BD Q30360288-044A4003-F3F9-4F59-8758-1885FCBBE8DE Q30360538-9E711BC1-F4EE-47DD-B2BD-3B98253BCDF8 Q30987054-8D085555-B8A8-49DA-8678-165B9941A6FB Q31127335-32E98224-DDA7-4DF0-9545-5492F359336D Q33611487-DA036B9E-79F3-42EA-87E8-12B34C1192B7 Q33649200-40F8A0A3-C0AD-4AF6-8044-DFC0DED48F14 Q33877898-11F8D254-9C0B-4F94-9338-9A6D3A486680 Q33998067-BA4E42E9-D8E7-403D-983D-6F5381EAB3E4 Q34050958-E6B55944-592C-4675-9EB2-91A2B985BCF6 Q34430776-DA2B41F1-CF9C-40EC-8DE9-91ED7ABF438D Q34626591-96B01904-B2F5-481F-BD35-89D38542C869 Q34712485-D1EB8DF6-CE5E-46B6-9A5F-F8342CD5FFE1 Q34813144-DECC5CA8-B775-44EC-BC31-C93B47264E6A Q35072020-7B092EDF-9FD0-46B0-AA01-286D740E5265 Q35114722-47CB9E1E-BB62-4AEC-B519-D8BC62D7DA58 Q35214000-7E88947D-87A8-4942-AD9F-E2DC4042ACC5 Q35488888-27298C3D-35C1-4526-BEEE-C127C6387D54 Q35611619-E684DDBC-A2B2-48A4-9DA0-D6CF4D1C2A3C Q35657944-A0678CDF-F5C5-4BFB-88A9-94DD74FBA936 Q35692221-33FBE4A4-285C-4203-9FF7-E48460FCEA01 Q35772369-B3D4B6C2-5A3A-43B4-9730-B94D1113EDF4 Q35814961-9E58BFF5-F4D1-4BF3-9652-297CC2A8C218 Q35874663-40E2D800-F51B-480D-B6EA-F5C0A7CCE6D4 Q35949941-2E7474A5-07CE-4333-B057-52846C010BE2 Q36250376-9BE8D622-3479-44FF-9E59-A72391CC9D72 Q36419552-361A9AEA-5249-4567-8EF8-C538A947C9C7 Q36514613-12D5124C-BE8B-4F6D-A894-24A695750BDB Q36956654-53A80F89-5EE4-42B2-8800-40158E30C7A6 Q37018340-918439AF-20DA-4B5E-A653-795AB001A935 Q37222229-F832CA18-952C-432B-B78E-232BD1A3C5A0 Q37418140-049C4DB2-E3BA-47DF-A948-5C3A030A2363 Q37625493-C5D439ED-423C-4B2F-9BE6-41992EEC011F Q37661603-1979B335-7350-44EB-9A4A-8F770335FF76 Q37665526-713A1E02-47FF-4ACB-B269-49C54E5ADB17 Q38181631-B7D3BF7F-A062-4A05-87E8-ABF513B87029 Q38649363-A4952DC6-1EBA-4051-A68C-3AA726FB2C72 Q38695606-C3EF0515-DCB1-487B-9C02-9AC83A2FE674 Q38749963-59F5B839-8876-42D4-B0DD-DF9B9B780DE7

P2860

The risk of incident coronary heart disease among veterans with and without HIV and hepatitis C

http://www.wikidata.org/entity/Q35174850

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

The risk of incident coronary ...... nd without HIV and hepatitis C

@ast

The risk of incident coronary ...... nd without HIV and hepatitis C

@en

type

label

The risk of incident coronary ...... nd without HIV and hepatitis C

@ast

The risk of incident coronary ...... nd without HIV and hepatitis C

@en

prefLabel

The risk of incident coronary ...... nd without HIV and hepatitis C

@ast

The risk of incident coronary ...... nd without HIV and hepatitis C

@en

P1433

Q35174850-9E631978-EFCD-4793-A60C-5629A0442529

P1476

Q35174850-EF195072-ED07-4F00-A331-980BA05CC560

P2093

Q35174850-07E6537C-FAE8-4D62-9E18-5089382F5CEA

Q35174850-18298B7C-5DAE-494B-B9C3-AA8FF5AEDB4B

Q35174850-26E49F45-08AC-4F79-B3F3-7B48987059F8

Q35174850-4532CF47-6721-469E-ACFD-046450889E47

Q35174850-57232E70-4BF2-4607-B9D4-6C64A7CE2FDF

Q35174850-6899A0AC-A6F3-41E0-BA37-FB71A2F93F90

Q35174850-7456EEB8-B6FD-4505-A416-A0C8F4AB86D5

Q35174850-76235C41-EFAB-423D-BDA7-1D081FABC963

Q35174850-76C28016-EADE-488F-B4E5-553DA99D4CBF

Q35174850-A8477D86-C363-4EAA-9884-09E1EEE75E54

P2860

Q35174850-082D9DAD-3531-41A8-BAFA-75B272D8B4E4

Q35174850-229C08BA-17B4-4C4C-A341-94E5446C8682

Q35174850-2F7E5175-BA8D-4B41-B3C6-DDC2418F26BA

Q35174850-3905A06A-FB89-48F9-9F67-4B9BECCAAC78

Q35174850-3DE33434-9F11-465D-B66D-EBF821086A17

Q35174850-577F5387-54E8-4CA3-A365-9224EF83F741

Q35174850-62F8163D-3524-41B8-A96A-C6939D0FA80E

Q35174850-6E1EF14E-C852-4910-BC4C-E5076DBD42F9

Q35174850-735E1855-D433-42B3-BCC0-13D23A81EF06

Q35174850-7546163E-8292-4002-9975-58CEF44386DC

P304

Q35174850-EFF4CF1A-890A-46C2-A6A7-BAD85F846645

P31

Q35174850-6B3393B7-F30E-47DB-8F3D-6EDCAF1EFCEF

P356

Q35174850-F32F3159-1544-4C74-BA25-0FB578878432

P433

Q35174850-67BC6848-1F36-42A4-B955-0EC34DD5B018

P478

Q35174850-E3AB384C-48E4-4388-909F-908C45FDC231

P50

Q35174850-4E425C20-CDE9-425B-BBD4-C9974F33768F

Q35174850-660931C5-0CEE-47E2-8E3A-4A584BF98039

Q35174850-6D66B930-89E6-47BB-A169-E5392D6F3C80

P577

Q35174850-9F81FB5E-6609-4C2C-83EE-627AF68E1EC3

P698

Q35174850-868E60A5-49C8-4913-84F2-94B9EAC0D16B

P921

Q35174850-4D2C4D39-5D15-426F-884C-D7103E09A39C

P932

Q35174850-D9888F6C-99E9-403F-A2E3-A4A6D0BB3652

P356

CIRCOUTCOMES.110.957415

P1433

Circulation: Cardiovascular Quality and Outcomes

P1476

The risk of incident coronary ...... nd without HIV and hepatitis C

@en

P2093

Adeel A Butt

http://www.w3.org/2001/XMLSchema#string

Amy C Justice

http://www.w3.org/2001/XMLSchema#string

Chung-Chou H Chang

http://www.w3.org/2001/XMLSchema#string

Cynthia Gibert

http://www.w3.org/2001/XMLSchema#string

David Leaf

http://www.w3.org/2001/XMLSchema#string

David Rimland

http://www.w3.org/2001/XMLSchema#string

Kathleen McGinnis

http://www.w3.org/2001/XMLSchema#string

Kendall Bryant

http://www.w3.org/2001/XMLSchema#string

Kevin L Kraemer

http://www.w3.org/2001/XMLSchema#string

Lewis H Kuller

http://www.w3.org/2001/XMLSchema#string

P2860

Microbial translocation is a cause of systemic immune activation in chronic HIV infection

Evidence for association between hepatitis C virus seropositivity and coronary artery disease

CD4+ count-guided interruption of antiretroviral treatment

Positive predictive value of the diagnosis of acute myocardial infarction in an administrative database.

Human immunodeficiency virus-related microbial translocation and progression of hepatitis C.

Hepatitis C virus infection and the risk of coronary disease.

The association between hepatitis C infection and prevalent cardiovascular disease among HIV-infected individuals

Rate and predictors of treatment prescription for hepatitis C.

Association between hepatitis C virus core protein and carotid atherosclerosis.

Hepatitis C virus and atherosclerosis in patients with type 2 diabetes.

P304

425-432

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/CIRCOUTCOMES.110.957415

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

Matthew B. Goetz

P577

2011-06-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21712519

http://www.w3.org/2001/XMLSchema#string

P921

P932

3159506

http://www.w3.org/2001/XMLSchema#string